Leronlimab (PRO 140) in vitro activity against 4-class drug resistant HIV-1 from heavily treatment experienced subjects

Authors

Keywords

Leronlimab, Drug resistance, Genotype, Phenotype, Human immunodeficiency virus type 1, Maraviroc

Journal

Volume 176, Issue -, Pages 106064

Publisher

Elsevier BV

Online

2022-01-07

DOI

10.1016/j.phrs.2022.106064

References

View 4 related references

Contact the author

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started